Nuvation Bio
NUVB
NUVB
116 hedge funds and large institutions have $204M invested in Nuvation Bio in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.84% less ownership
Funds ownership: 62.53% → 61.69% (-0.84%)
7% less funds holding
Funds holding: 125 → 116 (-9)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Holders
116
Holding in Top 10
3
Calls
$7K
Puts
$1K
Top Buyers
| 1 | +$5.29M | |
| 2 | +$2.59M | |
| 3 | +$1.75M | |
| 4 |
Renaissance Technologies
New York
|
+$1.65M |
| 5 |
Citigroup
New York
|
+$1.59M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.9M | |
| 3 | -$1.67M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$882K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$827K |